Physician
RJZM LLC
RJZM LLC was paid $7.68M by Medicaid between Jan 2018 and Aug 2022, across 103 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoRJZM LLC
RICHMOND HILL, NY 11418
RICHMOND HILL, NY 11418
33aNPI1437352119assigned 06/08/2007
33bProvider typeGeneral Practice Physician
28Total paid$7.68M
24GClaims107,495
24DCodes billed103
24AFirst – last monthJan 2018 – Aug 2022
Compared with peers
Next to other General Practice Physician providers in New York
Rank by total paid#6 of 178
Median peer was paid$27K
This provider vs. median286×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,632 | $372K | |
| 2019 | 14,425 | $1.12M | |
| 2020 | 31,482 | $2.58M | |
| 2021 | 31,396 | $2.27M | |
| 2022 | 26,560 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 38,417 | 29,479 | $4.21M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 7,904 | 6,176 | $788K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.1% | 4,641 | 3,705 | $545K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.9% | 7,957 | 2,883 | $296K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.3% | 2,134 | 1,328 | $250K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 1,894 | 1,807 | $243K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 2.3% | 2,962 | 2,811 | $179K |
| 11721 | 1.7% | 1,098 | 885 | $130K | |
| 99442 | 1.6% | 1,050 | 887 | $121K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.3% | 744 | 671 | $102K |
| 97162 | 1.3% | 773 | 726 | $99K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 4,932 | 2,395 | $91K |
91 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,664 | $69K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 560 | $68K |
| 97014 | <1% | 3,519 | $55K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 794 | $42K |
| 99406 | <1% | 922 | $40K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 197 | $38K |
| 97164 | <1% | 403 | $27K | |
| 97010 | <1% | 4,684 | $25K | |
| 99205 | Prolong outpt/office vis | <1% | 234 | $23K |
| 20553 | <1% | 81 | $22K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 522 | $20K |
| 97802 | <1% | 699 | $18K | |
| 97116 | <1% | 601 | $17K | |
| 99441 | <1% | 127 | $17K | |
| 99000 | <1% | 665 | $11K | |
| 11056 | <1% | 70 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,450 | $10K |
| 98968 | <1% | 75 | $10K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 50 | $9K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 66 | $9K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 125 | $9K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 60 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 283 | $6K |
| 20552 | <1% | 23 | $6K | |
| 99407 | <1% | 111 | $5K | |
| 97161 | <1% | 42 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 34 | $4K |
| 99408 | <1% | 154 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 240 | $4K |
| 11055 | <1% | 24 | $4K | |
| 90756 | <1% | 111 | $3K | |
| 80061 | Lipid panel | <1% | 311 | $3K |
| 82607 | <1% | 239 | $3K | |
| 82746 | <1% | 240 | $3K | |
| 99401 | <1% | 70 | $2K | |
| 80050 | General health panel | <1% | 135 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 308 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 163 | $2K |
| 94010 | <1% | 162 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 198 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 471 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 199 | $1K |
| 36410 | <1% | 57 | $855.49 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 28 | $819.66 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 67 | $768.94 |
| 97035 | <1% | 55 | $670.37 | |
| 81001 | <1% | 268 | $543.12 | |
| 99091 | <1% | 60 | $519.34 | |
| 99386 | <1% | 12 | $428.90 | |
| 84481 | <1% | 28 | $325.40 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 19 | $271.44 |
| 86803 | <1% | 23 | $209.97 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 146 | $196.10 |
| 84153 | <1% | 14 | $168.09 | |
| 84439 | <1% | 28 | $163.01 | |
| 82043 | <1% | 39 | $151.27 | |
| 87340 | <1% | 14 | $104.10 | |
| 82962 | <1% | 101 | $73.78 | |
| 84436 | <1% | 13 | $52.57 | |
| 86592 | <1% | 18 | $47.96 | |
| 76942 | <1% | 13 | $44.60 | |
| 93000 | <1% | 16 | $38.69 | |
| 94760 | <1% | 19 | $3.00 | |
| A4657 | Syringe, with or without needle, each | <1% | 45 | $2.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 289 | $0.02 |
| 3725F | <1% | 241 | $0.02 | |
| 3078F | 0% | 613 | $0.00 | |
| 1160F | 0% | 2,837 | $0.00 | |
| 3077F | 0% | 463 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 75 | $0.00 |
| 1158F | 0% | 31 | $0.00 | |
| 99078 | 0% | 176 | $0.00 | |
| 1124F | 0% | 31 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 47 | $0.00 |
| 3051F | 0% | 13 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 20 | $0.00 |
| 1159F | 0% | 31 | $0.00 | |
| 1125F | 0% | 1,081 | $0.00 | |
| 99606 | 0% | 15 | $0.00 | |
| 3044F | 0% | 470 | $0.00 | |
| 3074F | 0% | 706 | $0.00 | |
| 3008F | 0% | 1,659 | $0.00 | |
| 3080F | 0% | 239 | $0.00 | |
| 1170F | 0% | 31 | $0.00 | |
| 3075F | 0% | 227 | $0.00 | |
| A4209 | Syringe with needle, sterile 5 cc or greater, each | 0% | 52 | $0.00 |
| 3351F | 0% | 99 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 29 | $0.00 |
| 3079F | 0% | 298 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSLINGSBY, EILEEN (ADMINISTRATOR)
Parent organizationRJZM LLC
| Provider | Location | Paid |
|---|---|---|
| RJZM LLC | Bronx, NY | $830K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.